Frazier Life Sciences Management’s MannKind Corp MNKD Stock Holding History

Frazier Life Sciences Management’s Portfolio MNKD Stock Details MNKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.1M	Buy	6,600,000 +700,000	+12%	+$2.27M	0.61%	27
2026 Q1	$14.5M	Buy	5,900,000 +1,675,000	+40%	+$7.47M	0.37%	31
2025 Q4	$24M	Buy	+4,225,000	New	+$23.3M	0.64%	29

Other funds holding MNKD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return

Frazier Life Sciences Management's MNKD Position: Q2 2026 in Review

Frazier Life Sciences Management increased its MannKind Corp (MNKD) stake by 12% in Q2 2026, buying an estimated $2.27M and bringing the position to 6,600,000 shares worth $28.1M. The position accounts for 0.61% of the portfolio, ranked #27.

Frazier Life Sciences Management first reported a position in MNKD in Q4 2025 and has held it in 3 quarters since. 258 funds tracked by Wall St. Rank hold MNKD as of Q2 2026.

Frazier Life Sciences Management held 6,600,000 shares of MannKind Corp worth $28.1M as of Q2 2026.
Frazier Life Sciences Management bought 700,000 MannKind Corp shares in Q2 2026, an estimated $2.27M.
MannKind Corp made up 0.61% of Frazier Life Sciences Management's portfolio in Q2 2026, its #27 holding.
Frazier Life Sciences Management first reported a position in MannKind Corp in Q4 2025 and has held it in 3 quarters since.
258 funds tracked by Wall St. Rank held MannKind Corp as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.